Large-scale testing (Phase 3)Study completedNCT05317767
What this trial is testing
The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.
Who this might be right for
Influenza
St. Petersburg Research Institute of Vaccines and Sera 600